Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone Therapy for Heart Failure Prevention in Peri-Menopausal Women
NCT02693002Phase 4Terminated
- Start
- Feb 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol + norethindrone in heart failure (HF). Started Feb 2016; status: terminated.
02
Drugs
estradiol + norethindrone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02693002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693002.